Few athletes in sports history have entered the professional ranks with more hype and intrigue than Caitlin Clark. She’s a bonafide superstar — a transcendent sports figure on and off the court. The ...

Vacant seats, and consistently poor attendance on both sides of the aisle, have exacerbated the challenges of already razor-thin margins in the House and Senate. By Ashley Wu and Robert Jimison See ...

EXCLUSIVE: Johnny Knoxville is hosting another hit. Fox has renewed Fear Factor: House of Fear, its new take on the classic competition series, for a second season. It comes less than a month after ...

Tel Aviv-based quantum computing startup Q-Factor announced itself to the world today after closing on a $24 million seed funding round. The company’s mission is to develop a neutral atom-based ...

Investors and dealmakers preparing for SpaceX’s upcoming $1.75 trillion IPO must reckon with one of the most powerful—and dangerous—variables in public equities: the Musk Effect. Tesla’s TSLA stock ...

“Fear Factor” is continuing its Johnny Knoxville-led new season, “House of Fear,” for its 9th episode and this time, contestants are facing off with a human claw machine. The show will also continue ...

International Business Machines stock is getting slammed Monday, becoming the latest perceived victim of rapidly developing AI technology, after Anthropic said its Claude Code tool could be used to ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andy Brinkmeyer shares how engineering ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

‘Fear Factor: House of Fear’ and ‘Memory of a Killer’ also scored well, with an on-air assist from the NFL. By Rick Porter Television Business Editor With some on-air help from the NFL, three Fox ...

Bristol Myers Squibb and Johnson & Johnson have begun an educational campaign about the factor XIa pathway, laying the groundwork for a launch that could follow phase 3 readouts expected this year.